Today's Veterinary Practice provides comprehensive information to keep every small animal practitioner up to date on companion animal medicine and surgery as well as practice building and management.
Issue link: http://todaysveterinarypractice.epubxp.com/i/919967
of dog owners agree that their pets should have 12 months of flea and tick protection 7 The average dog owner applies approximately 4.6 monthly flea treatments in a year. 8 Pet owners prefer BRAVECTO ® 9 to 1 over monthly treatments 9 Ask your Merck Animal Health Rep about BRAVECTO ® or visit Bravectovets.com 1 BRAVECTO ® Chew for Dogs [prescribing information]. Madison, NJ: Merck Animal Health; 2014. 2 BRAVECTO ® Topical Solution for Dogs [prescribing information]. Madison, NJ: Merck Animal Health; 2016. 3 BRAVECTO ® Topical Solution for Cats [prescribing information]. Madison, NJ: Merck Animal Health; 2016. 4 Rohdich N et al. Parasites & Vectors. 2014;7:83. 5 Freedom of Information Summary, NADA 141-426. Approved May 15, 2014. 6 Freedom of Information Summary, NADA 141-459. Approved 2016. 7 Lavan et al. P&V.; 2017; 10:284. 8 Brakke Consulting US Flea Control & Heartworm Markets report; 2015. 9 Lavan et al. J Vet Sci Technol. 2017; 8:439. * BRAVECTO ® kills fleas and prevents flea infestations for 12 weeks. BRAVECTO ® Chew and BRAVECTO ® Topical Solution for Dogs kills ticks (black-legged tick, American dog tick, and brown dog tick) for 12 weeks and also kills lone star ticks for 8 weeks. BRAVECTO ® Topical Solution for Cats kills ticks (black-legged tick) for 12 weeks and American dog ticks for 8 weeks. IMPORTANT SAFETY INFORMATION: BRAVECTO ® has not been shown to be effective for 12-weeks' duration in puppies or kittens less than 6 months of age. BRAVECTO ® Chew and BRAVECTO ® Topical Solution for Dogs: The most common adverse reactions recorded in clinical trials were vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. BRAVECTO ® is not effective against lone star ticks beyond 8 weeks of dosing. BRAVECTO ® Topical Solution for Cats: The most common adverse reactions recorded in clinical trials were vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. BRAVECTO ® is not effective against American dog ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. The safety of BRAVECTO ® has not been established in breeding, pregnant and lactating cats. Use with caution in cats with a history of neurologic abnormalities. Neurologic abnormalities have been reported in cats receiving BRAVECTO ® , even in cats without a history of neurologic abnormalities. Copyright © 2018 Intervet Inc., d/b/a Merck Animal Health, a subsidiary of Merck & Co. Inc. All rights reserved. US/BRV/1117/0105 ¨ BRAVECTO ® can help close the compliance gap Veterinarians recommend year-round flea and tick protection What do dog owners think? 62% of dog owners remembered their veterinarian's exact recommendation 7 73% Is everyone following the 12-month recommendation? No. See full Prescribing Information on page 2.